Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists

(1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists

US Patent 5614519 · Granted Mar 25, 1997

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of tetrahydropyridines in the treatment of sodium channel related disease an2019
Stereoselective process2019
Substituted glycinamides, process for their manufacture and use thereof as medic2017
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrop2017
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrop2017
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrop2016
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrop2016
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrop2016
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrop2016
Substituted glycinamides, process for their manufacture and use thereof as medic2015
1H-benzimidazole-5-carboxamides as anti-inflammatory agents2015
Methods of using antibodies during anticoagulant therapy of dabigatran and/or re2015